Federal Register / Vol. 82, No. 185 / Tuesday, September 26, 2017 / Notices 44821 

surveillance systems to monitor HIV/ 

HCV coinfections among low-income or 

underinsured, racial and ethnic 

minority populations. HRSA–17–047 

recipients and subrecipients will require 

similar evaluation and technical 

assistance in order to meet the 

program’s goals and objectives. 

Supplemental funding to the existing 

ETAC is a cost effective and efficient 

solution that will leverage RAND 

Corporation’s currently funded 

infrastructure to include the additional 

sites funded under HRSA–17–047. 

Further, this supplemental funding will 

leverage RAND’s current work by 

combining and comparing evaluation 

results across all jurisdictions from both 

initiatives and facilitate the streamlining 

and integration of processes and 

technical assistance. Supplemental 

funding will also provide opportunities 

for RAND Corporation to create joint 

learning networks and build on lessons 

learned from the initial cohort of 

jurisdictional sites currently in the 

second year of implementation. Not 

issuing this award would result in a lack 

of evaluation and technical assistance 

for HRSA–17–047 recipients and 

subrecipients, which is critical to 

achieving the initiative’s goal to cure 

HCV among HIV/HCV coinfected people 

of color. 

FOR FURTHER INFORMATION CONTACT: Mr. 

Adan Cajina, Chief, Demonstration 

Evaluation Branch, Office of Training 

and Capacity Development, Division of 

HIV Domestic Programs, HIV/AIDS 

Bureau, HRSA, 5600 Fishers Lane, 

09N108, Rockville, MD 20857, Phone: 

(301) 443–3180, Email: acajina@

hrsa.gov. 

Dated: September 19, 2017. 

George Sigounas, 

Administrator. 

[FR Doc. 2017–20544 Filed 9–25–17; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Frederick National 

Laboratory Advisory Committee to the 

National Cancer Institute. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. The meeting 

will also be videocast and can be 

accessed from the NIH Videocasting and 

Podcasting Web site (http://

videocast.nih.gov/). 

Name of Committee: Frederick National 

Laboratory Advisory Committee to the 

National Cancer Institute 

Date: October 30, 2017. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: Ongoing and new activities at the 

Frederick National Laboratory for Cancer 

Research. 

Place: National Institutes of Health, 31 

Center Drive, Building 31, Wing C; 6th Floor, 

Conference Room 10, Bethesda, MD 20892. 

Contact Person: Caron A. Lyman, Ph.D. 

Executive Secretary, National Cancer 

Institute, National Institutes of Health, 9609 

Medical Center Drive, Room 7W–126, 

Bethesda, MD 20892, 240–276–6348 

lymanc@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http://

deainfo.nci.nih.gov/advisory/fac/fac.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: September 20, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–20487 Filed 9–25–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the NHLBI Special Emphasis 

Panel. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Grant Review for NHLBI K Award Recipients. 

Date: October 17, 2017. 

Time: 12:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Suite 7202, Bethesda, MD 

20892 (Telephone Conference Call). 

Contact Person: Melissa E Nagelin, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review/DERA, National Heart, Lung, and 

Blood Institute, 6701 Rockledge Drive, Room 

7202, Bethesda, MD 20892, 301–435–0297, 

nagelinmh2@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: September 20, 2017. 

Michelle Trout, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–20489 Filed 9–25–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

44822 Federal Register / Vol. 82, No. 185 / Tuesday, September 26, 2017 / Notices 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Medicinal Chemistry. 

Date: October 16–17, 2017. 

Time: 10:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Mike Radtke, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4176, 

MSC 7806, Bethesda, MD 20892, 301–435– 

1728, radtkem@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR Panel: 

Education and Health: New Frontiers. 

Date: October 16, 2017. 

Time: 12:05 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: John H Newman, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3222, 

MSC 7808, Bethesda, MD 20892, (301) 435– 

0628, newmanjh@csr.nih.gov. 

Name of Committee: Oncology 1-Basic 

Translational Integrated Review Group; 

Tumor Cell Biology Study Section. 

Date: October 18–19, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Alexandria Old Town, 167 

King Street, Aexandria, VA 22314. 

Contact Person: Charles Morrow, MD, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6202, 

MSC 7804, Behesda, MD 20892, 301–408– 

9850, morrowcs@csr.nih.gov. 

Name of Committee: Healthcare Delivery 

and Methodologies Integrated Review Group; 

Dissemination and Implementation Research 

in Health Study Section. 

Date: October 18–19, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaylord National Resort and 

Convention Center, 201 Waterfront Street, 

National Harbor, MD 20745. 

Contact Person: Yvonne Owens Ferguson, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive Room 3139, 

Bethesda, MD 20892, 301–827–3689, 

fergusonyo@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR15–162: 

Pilot and Feasibility Clinical Research Grants 

in Urologic Disorders. 

Date: October 18, 2017. 

Time: 10:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Ganesan Ramesh, Ph.D., 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Dr. 

Room 2182 MSC 7818, Bethesda, MD 20892, 

301–827–5467, ganesan.ramesh@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Academic 

Research Enhancement Award. 

Date: October 18, 2017. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Jian Cao, Ph.D., Scientific 

Review Officer, Center for Scientific Review, 

6701 Rockledge Drive, Bethesda, MD 20892, 

301–827–5902, caojn@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846-93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: September 20, 2017. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–20484 Filed 9–25–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of Allergy, Immunology, and 

Transplantation Research Committee. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Allergy, Immunology, 

and Transplantation Research Committee. 

Date: October 19–20, 2017. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 5601 

Fishers Lane, Rockville, MD 20892 

(Telephone Conference Call). 

Contact Person: James T. Snyder, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities/ 

Room 3G31B National Institutes of Health, 

NIAID, 5601 Fishers Lane MSC 9834, 

Bethesda, MD 20892–9834, (240) 669–5060, 

james.snyder@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: September 20, 2017. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–20493 Filed 9–25–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Advancing 

Translational Sciences; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Advancing Translational Sciences Special 

Emphasis Panel; Conference Grants Review. 

Date: November 8, 2017. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, DEM1, 

Room 1065, 6701 Democracy Blvd., 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Carol Lambert, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review, National Center for Advancing 

Translational Sciences (NCATS), National 

Institutes of Health, 6701 Democracy Blvd., 

Democracy 1, Room 1076, Bethesda, MD 

20892, 301–435–0814, lambert@mail.nih.gov.